A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Condition:   Non-muscle-invasive Bladder Cancer Intervention:   Drug: STM-416 Sponsor:   SURGE Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials